Phase
Condition
Fragile X Syndrome
Williams Syndrome
Sjögren-larsson Syndrome
Treatment
Standard of care genetic testing group
Clinical Study ID
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Individual with a genomic aberration identified by CMA, karyotyping, Southern blotanalysis, PCR, FISH, and/or NGS or other standard of care (SOC) genetic testingtechnology whose clinical test results are available to compare with results from OGM.
- Patients with prior negative SOC genetic testing results whose results are availableto compare with results from OGM.
Exclusion
Exclusion Criteria:
- Any individual who opted-out of research at the testing laboratory.
- An individual whose genetic test contains the following variants: pathogenic sequencevariants, abnormalities involving acrocentric p-arms and centromeres, below 20% formosaicism, and tetraploidy.
Study Design
Study Description
Connect with a study center
Praxis Genomics
Atlanta, Georgia 30328
United StatesSite Not Available
Augusta University Research Institute
Augusta, Georgia 30912
United StatesSite Not Available
University of Iowa Hospitals & Clinics, Molecular Pathology
Iowa City, Iowa 52242
United StatesSite Not Available
Columbia University Irving Medical Center
New York, New York 10032
United StatesSite Not Available
DNA Microarray CGH Laboratory, Department of Pathology, University of Rochester Medical Center
W. Henrietta, New York 14586
United StatesSite Not Available
Greenwood Genetic Center
Greenwood, South Carolina 29646
United StatesActive - Recruiting
Lineagen (A Bionano Genomics Company)
Salt Lake City, Utah 84109
United StatesActive - Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin 53226
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.